Skip to main content

Brian J. Shea


[email protected]



Brian’s practice focuses on corporate transactional matters with an emphasis on securities offerings, corporate governance and ongoing reporting requirements for publicly traded companies, their officers and directors. Brian regularly represents both issuers and underwriters in capital markets transactions, including initial public offerings and follow-on equity offerings.

Prior to joining Mintz, Brian worked at a prominent financial technology firm based in Boston. There he managed the company’s fiduciary consulting services centered on antitrust and competition-based class actions, non-U.S. group securities actions, and other strategic litigation opportunities impacting institutional investors.

While in law school, Brian served as Editor-in-Chief of the William & Mary Business Law Review. Before earning his law degree, Brian worked as a capital markets analyst for a leading global law firm in New York.


  • William and Mary Law School (JD, cum laude)
  • Dartmouth College (BA)


- Spanish


Snap Inc., which debuted on the New York Stock Exchange (NYSE) on March 2nd, was the largest tech IPO since Alibaba went public in 2014.  Initially priced at $17 per share, the share price jumped to more than $24 by the end of the first trading day, raising $3.4 billion and beating market expectations.
Read more

News & Press

Mintz represented G1 Therapeutics, Inc. in its initial public offering of 7,781,564 shares of common stock. G1 Therapeutics is a clinical-stage biopharmaceutical company.
Mintz Corporate & Securities attorney Brian Shea addresses concerns regarding Snap Inc.’s IPO. The IPO has raised interesting governance issues around its nonvoting shares, which the SEC Investor Advisory Committee (IAC) looked into.